Last reviewed · How we verify
NCT05603728
Exactech Shoulder Post Market Clinical Follow-up Study
trial in Osteo Arthritis Shoulders in 20,000 participants. Currently enrolling.
31 December 2030
Quick facts
| Lead sponsor | Exactech |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20,000 |
| Start date | 19 July 2007 |
| Primary completion | 31 December 2030 |
| Estimated completion | 31 December 2031 |
| Sites | 38 locations across France, Italy, United Kingdom, Canada, United States |
Conditions studied
- Osteo Arthritis Shoulders — all drugs for Osteo Arthritis Shoulders →
- Osteonecrosis — all drugs for Osteonecrosis →
- Rotator Cuff Tears — all drugs for Rotator Cuff Tears →
- Rotator Cuff Tear Arthropathy — all drugs for Rotator Cuff Tear Arthropathy →
Sponsor
Exactech
Who can join
21 and older, any sex, with Osteo Arthritis Shoulders or Osteonecrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder arthroplasty over time. This study will follow subjects long-term for a minimum of 10-years, without an early-term restriction on the amount of time they will be followed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05603728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteo Arthritis Shoulders
Currently open trials in the same condition.
- NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting
- NCT05700682 — Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee · recruiting
- NCT04238143 — Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis · NA · recruiting
- NCT04529798 — Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless · recruiting
Other Exactech trials
Trials by the same sponsor.
- NCT05849961 — Exactech Hip Systems Post-Market Clinical Follow-up (PMCF) · recruiting
- NCT05703958 — Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up · recruiting
- NCT05615259 — Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty · recruiting
- NCT05691868 — Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US) · recruiting
- NCT05653102 — A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05603728 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Exactech
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05603728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing